Merck, Glenmark Can Introduce 'Justifications' In Zetia Trial

By Nadia Dreid · April 12, 2023, 10:03 PM EDT

Merck and Glenmark will be able to tell a jury the reasons they believe their decision to delay generic competition for the cholesterol medication Zetia was actually good for consumers after...

To view the full article, register now.

Documents

Case Information

Case Title

In Re: Zetia (Ezetimibe) Antitrust Litigation

Case Number

2:18-md-02836

Court

Virginia Eastern

Nature of Suit

Anti-Trust

Date Filed

June 15, 2018